News

Updates on activities and accomplishments at AYOXXA

As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.

Customer Testimonials

Webinars

Coronavirus Update

Conferences

Meet AYOXXA

AYOXXA @ "iSearch"

iSearch is a forum for basic experimental research in ophthalmology, where new findings about signaling pathways and pathomechanisms involving immune cells of the retina are presented. Young scientists as well as experienced investigators and leading ophthalmologists in the field advance the area of translational research to develop new therapies for inflammatory eye diseases.

Read more

Meet AYOXXA

AYOXXA @ Cytokines 2019

The 7th Annual Meeting of the International Cytokine & Interferon Society will be held at the Hofburg Conference Centre, an international conference and event centre in the Austrian capital Vienna.

Read more

Meet AYOXXA

AYOXXA @ DGfI & SIICA 2019

The German Society for Immunology (DGfI) and Italian Society for Immunology, Clinical Immunology and Allergology (SIICA) will host their joint meeting this year in Munich from 10 – 13 September.

Read more

Meet AYOXXA

AYOXXA @ BIO Convention 2019

Every year, the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States hosts the BIO International Convention. This year features discussions and networking opportunities with over 16,000 biotech leaders from 67 countries and AYOXXA will be a part of it!

Read more

Meet AYOXXA

AYOXXA @ ARVO Annual Meeting 2019

Over 12,000 experts are convening in Vancouver, Canada, for the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest international eye and vision conference.

Read more

Meet AYOXXA

AYOXXA @ 13th World Immune Regulation Meeting

Hosted in beautiful Davos, Switzerland, the internationally renowned World Immune Regulation Meeting (WIRM) brings together around 600 scientists from all over the world to discuss the latest findings in immunology, from immune activation and effector functions to immune tolerance and autoimmunity.

Read more

Press Reviews

Press Review

Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA

BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.

Read more

Press Review

Meet Rodney Turner, CEO of Multiplex Protein Analysis Company AYOXXA

BIO-Europe offers many opportunities. One of them is meeting with companies’ representatives to have a chat. In this context, we met with Rodney Turner, CEO of German company AYOXXA, which markets a technology for multiplex protein analysis.Although it may sound complicated, the technology is quite straightforward. Simply put, it is the parallel analysis of multiple proteins from one single, very small sample.

Read more

Press Review

Beads-on-a-Chip-Multiplex-System: Analyse kleinster Volumina (Laborpraxis)

Ayoxxa Biosystems präsentiert mit Lunaris ein Bead-basiertes Multiplex-System zur Analyse kleinster Proteinprobenvolumina.

Read more

Press Review

AYOXXA launches new beads-on-a-chip multiplex protein

AYOXXA Biosystems (Cologne, Germany) have introduced a novel system, termed LUNARIS™, which is aimed to quantify soluble inflammation and immune response markers...

Read more

Press Releases

Press Release

AYOXXA @ BIO-Europe Spring 2018 - 12th International Partnering Conference

AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, will participate in the upcoming BIO-Europe Spring®

Read more

Press Release

AYOXXA launches LUNARIS™ Human 11-Plex Ophthalmology Kit

For multiplexed analysis of biomarker signatures in ocular fluids including vitreous and aqueous samples. Covering: angiogenic & inflammatory factors, chemokines known to be relevant in the pathology of retinal angiogenic diseases next to VEGF, the target molecule of today’s standard of care.

Read more

Press Release

AYOXXA develops multiplex assay for stratification of sepsis patients using soluble biomarkers

AYOXXA Biosystems GmbH joined "SepsisDataNet.NRW" research project funded by EFRE and comprises a consortium of NRW companies, university hospitals and universities. Funding started in July 2017 for a period of three years.

Read more

Press Release

AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit to elucidate Th17 cell biology

LUNARIS™ Mouse 12-Plex Th17 Kit comprises highly specific reagents for the quantitative analysis of soluble markers of Th17 cell biology Kit includes the primary Th17 related cytokines involved in autoimmune disorders, immune-mediated diseases as well as asthma, allergy, cancer, microbial defense and transplantation Launch marks a further step in establishing AYOXXA’s LUNARIS™ as the technology of choice for fully scalable beads-on-a-chip multiplex

Read more

Press Release

AYOXXA introduces LUNARIS™, its advanced fully integrated low-volume beads-on-a-chip multiplex protein analysis system

AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.

Read more

Press Release

AYOXXA is Member of the International EYE-RISK Consortium

Cologne 22 October 2015 - AYOXXA Biosystems GmbH, an international biotechnology company, is one of two industrial partners of EYE-RISK, a large biomedical consortium bringing together the expertise of ten renown scientific and clinical institutions and a patient organization from six European countries. It is led by Prof. Dr.

Read more

Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.